Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type (FSH, Insulin), By Technology (Tandem Mass Spectrometry, Immunoassay), By End-use, By Region, And Segment Forecasts, 2023

The global endocrine testing market size is expected to reach USD 21.42 billion by 2030, registering a CAGR of 8.4% during the forecast period, according to a new report by Grand View Research, Inc.. The growing prevalence of life style diseases such as obesity coupled with diabetes & thyroid among the adult as well as the geriatric population is driving the need for endocrine testing. The routine endocrine testing in individuals will help in overall maintenance of health and thus this awareness of better health is significantly contributing to the global endocrine testing market growth.

As per the statistics by WHO, more than 39 million children in 2020 who were under the age of 5 were overweight or obese. The sedentary life along with unhealthy diet choices have contributed to obesity as well as diabetes in the general population. This occurrence of diseased conditions has also prompted many researches into the metabolic functions and related hormonal disorders.

Funding from government and private organizations has also driven the scientific community. For instance, the NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) by NIH drives many sponsored research programs towards improving health by better understanding of diseases. One such effort by NIDDK was the mid-atlantic symposium conducted in September 2022 for diabetes and obesity research. This will enable scientific knowledge exchange and interactions and allow collaboration at the regional level. Such initiatives will drive the understanding of endocrine function in the human body and will further enable the endocrine testing market growth.

The lack of awareness in underdeveloped and developing countries is anticipated to slow the growth of endocrine testing market. The developing health care settings and absence of reimbursement models restrain the individuals in these regions to undergo routine endocrine testing. However, with the growing consciousness of a healthy system during the COVID-19 pandemic is expected to upswing the testing frequency for these countries as well.

The outbreak of COVID-19 has created lucrative opportunities for the application of endocrine testing. COVID-19 infections cause a systemic disease that injures many organs. Therefore, these patients have many metabolic and hormonal disturbances that led to an increase in the number of endocrine research. For instance, in March 2021, Endocrine society members sanctioned USD 10 billion to support COVID-19 research to identify and understand the short and long-term COVID-19 effects on the endocrine system. Similarly, in September 2020, The American Diabetes Association invested USD 1 million to fund various research projects for investigating the link between diabetes and COVID-19. Thus, it will increase the demand and further boost market growth.

In addition, the limitation of movement and restrictions due to the lockdown encouraged the digital platform for medical consultation and at home sample collection services as well. The availability of point-of-care devices and kits for the detection of hormone levels at home is also driving the overall growth of endocrine testing market.

The market players are also expanding their regional presence due to various factors that are anticipated to grow the endocrine testing market. Collaboration, partnerships and global expansions are some of the business strategies by the key players to drive revenue generation. For instance, in February 2022 Laboratory Corporation of America Holdings (Labcorp) announced opening of a new laboratory in Indiana, U.S. The new diagnostics business in South Bend, Indiana will enhance the company's services and make their offerings accessible to both patients as well as physicians in this region.

Endocrine Testing Market Report Highlights:

By test type, the human Chorionic Gonadotropin (hCG) hormone testing accounted for the largest share in 2022, driven by the presence of self-test kits at pharmacy stores, along with tests in laboratories or hospitals for quantitative evaluation. Moreover, the frequency of testing during different weeks of pregnancy and high number of fertile female population are also the contributing factors.
By technology, immunoassay dominated the 2022 market, owing to the presence of instruments by key players which uses immunoassay-based detection techniques. The large number of instruments and test panels which rely on immunoassay technology, drives the endocrine testing market growth.
By end-user, commercial laboratories contributed majorly to the revenue generation in 2022. The feasibility & availability of variety of testing panels for endocrinology and reproductive functions, services like at home collection and presence of digital platforms led to the increased segment share.
North America had the highest revenue generated in 2022 for endocrine testing market. This is attributed to the vast presence of thyroid disorders, diabetes and obesity within the US population. Additionally, developed healthcare and increased spending pattern in this region also led to higher revenue generation.

Product Code: 978-1-68038-862-6

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Test Type
- 1.1.2. Technology
- 1.1.3. End-use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Test Type outlook
- 2.2.2. Technology outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Endocrine Testing Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
3.4. Endocrine Testing Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic landscape

Chapter 4. Endocrine Testing: Test Type Estimates & Trend Analysis

4.1. Endocrine Testing Market: Key Takeaways
4.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Estradiol (E2) Test
- 4.3.1. Estradiol (E2) test market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Follicle Stimulating Hormone (FSH) Test
- 4.4.1. Follicle Stimulating Hormone (FSH) test market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Human Chorionic Gonadotropin (hCG) Hormone Test
- 4.5.1. Human Chorionic Gonadotropin (hCG) hormone test market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Luteinizing Hormone (LH) Test
- 4.6.1. Luteinizing Hormone (LH) test market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Dehydroepiandrosterone Sulfate (DHEAS) Test
- 4.7.1. Dehydroepiandrosterone Sulfate (DHEAS) test market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Progesterone Test
- 4.8.1. Progesterone test market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Testosterone Test
- 4.9.1. Testosterone test market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Thyroid Stimulating Hormone (TSH) Test
- 4.10.1. Thyroid Stimulating Hormone (TSH) test market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Prolactin Test
- 4.11.1. Prolactin test market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Cortisol Test
- 4.12.1. Cortisol test market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. Insulin Test
- 4.13.1. Insulin test market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. Others
- 4.14.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Endocrine Testing: Technology Estimates & Trend Analysis

5.1. Endocrine Testing Market: Key Takeaways
5.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Tandem Mass Spectrometry
- 5.3.1. Tandem mass spectrometry market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Immunoassay
- 5.4.1. Immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Monoclonal & Polyclonal Antibody Technologies
- 5.5.1. Monoclonal & polyclonal antibody technologies market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Sensor Technology
- 5.6.1. Sensor technology market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Clinical Chemistry
- 5.7.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Others
- 5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Endocrine Testing: End-use Estimates & Trend Analysis

6.1. Endocrine Testing Market: Key Takeaways
6.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
- 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Commercial Laboratories
- 6.4.1. Commercial laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Ambulatory Care Centers
- 6.5.1. Ambulatory care centers market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Others
- 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Endocrine Testing Market: Regional Estimates & Trend Analysis

7.1. Regional Outlook
7.2. Endocrine Testing Market by Region: Key Marketplace Takeaway
7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
- 7.4.1. UK
  - 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
  - 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
  - 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
  - 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Sweden
  - 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Norway
  - 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Denmark
  - 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
- 7.5.1. Japan
  - 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
  - 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
  - 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
  - 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
  - 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
  - 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
- 7.6.1. Brazil
  - 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
  - 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
- 7.7.1. Saudi Arabia
  - 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
  - 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
  - 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
- 8.2.1. Abbott Laboratories
  - 8.2.1.1. Company overview
  - 8.2.1.2. Financial performance
  - 8.2.1.3. Product benchmarking
  - 8.2.1.4. Strategic initiatives
- 8.2.2. AB Sciex
  - 8.2.2.1. Company overview
  - 8.2.2.2. Financial performance
  - 8.2.2.3. Product benchmarking
  - 8.2.2.4. Strategic initiatives
- 8.2.3. Agilent Technologies Inc.
  - 8.2.3.1. Company overview
  - 8.2.3.2. Financial performance
  - 8.2.3.3. Product benchmarking
  - 8.2.3.4. Strategic initiatives
- 8.2.4. bioMerieux SA
  - 8.2.4.1. Company overview
  - 8.2.4.2. Financial performance
  - 8.2.4.3. Product benchmarking
  - 8.2.4.4. Strategic initiatives
- 8.2.5. Bio-Rad Laboratories Inc.
  - 8.2.5.1. Company overview
  - 8.2.5.2. Financial performance
  - 8.2.5.3. Product benchmarking
  - 8.2.5.4. Strategic initiatives
- 8.2.6. DiaSorin S.p.A.
  - 8.2.6.1. Company overview
  - 8.2.6.2. Financial performance
  - 8.2.6.3. Product benchmarking
  - 8.2.6.4. Strategic initiatives
- 8.2.7. F. Hoffmann-La Roche Ltd.
  - 8.2.7.1. Company overview
  - 8.2.7.2. Financial performance
  - 8.2.7.3. Product benchmarking
  - 8.2.7.4. Strategic initiatives
- 8.2.8. Laboratory Corporation of America Holdings
  - 8.2.8.1. Company overview
  - 8.2.8.2. Financial performance
  - 8.2.8.3. Product benchmarking
  - 8.2.8.4. Strategic initiatives
- 8.2.9. Quest Diagnostics Incorporated
  - 8.2.9.1. Company overview
  - 8.2.9.2. Financial performance
  - 8.2.9.3. Product benchmarking
  - 8.2.9.4. Strategic initiatives
- 8.2.10. Ortho Clinical Diagnostics
  - 8.2.10.1. Company overview
  - 8.2.10.2. Financial performance
  - 8.2.10.3. Product benchmarking
  - 8.2.10.4. Strategic initiatives

Product Code: 978-1-68038-862-6

List of Tables

Table 1 List of abbreviations
Table 2 North America endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 3 North America endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 4 North America endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 5 North America endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 7 U.S. endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 10 Canada endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 11 Canada endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 13 Europe endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 14 Europe endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 16 Germany endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 17 Germany endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 18 Germany endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 20 UK endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 21 UK endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 22 France endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 23 France endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 24 France endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 26 Italy endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 27 Italy endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 29 Spain endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 30 Spain endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 31 Sweden endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 32 Sweden endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 33 Sweden endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 34 Norway endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 35 Norway endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 36 Norway endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 37 Denmark endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 38 Denmark endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 39 Denmark endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 42 Asia Pacific endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 44 China endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 45 China endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 46 China endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 48 Japan endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 49 Japan endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 50 India endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 51 India endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 52 India endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 53 Australia endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 54 Australia endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 55 Australia endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 56 Thailand endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 57 Thailand endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 58 Thailand endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 59 South Korea endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 60 South Korea endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 61 South Korea endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 63 Latin America endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 64 Latin America endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 65 Latin America endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 67 Brazil endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 68 Brazil endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 70 Mexico endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 71 Mexico endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 73 Argentina endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 74 Argentina endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 80 South Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 81 South Africa endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 86 UAE endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 87 UAE endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 89 Kuwait endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 90 Kuwait endocrine testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Endocrine testing: Market outlook
Fig. 9 Endocrine testing: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Endocrine testing market driver impact
Fig. 15 Endocrine testing market restraint impact
Fig. 16 Endocrine testing market strategic initiatives analysis
Fig. 17 Endocrine testing market: Test type movement analysis
Fig. 18 Endocrine testing market: Test type outlook and key takeaways
Fig. 19 Estradiol (E2) test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Follicle Stimulating Hormone (FSH) test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Human Chorionic Gonadotropin (hCG) hormone test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Luteinizing Hormone (LH) test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Dehydroepiandrosterone Sulfate (DHEAS) test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Progesterone test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Testosterone test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Thyroid Stimulating Hormone (TSH) test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Prolactin test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Cortisol test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Insulin test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Endocrine testing market: Technology movement analysis
Fig. 32 Endocrine testing market: Technology outlook and key takeaways
Fig. 33 Tandem mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Monoclonal & polyclonal antibody technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Sensor technology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Endocrine testing market: End-use movement analysis
Fig. 40 Endocrine testing market: End-use outlook and key takeaways
Fig. 41 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Commercial laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Ambulatory care centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Global endocrine testing market: Regional movement analysis
Fig. 46 Global endocrine testing market: Regional outlook and key takeaways
Fig. 47 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type (FSH, Insulin), By Technology (Tandem Mass Spectrometry, Immunoassay), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Description

Table of Contents

List of Tables

Endocrine Testing Market Growth & Trends:

Endocrine Testing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Endocrine Testing Market Variables, Trends & Scope

Chapter 4. Endocrine Testing: Test Type Estimates & Trend Analysis

Chapter 5. Endocrine Testing: Technology Estimates & Trend Analysis

Chapter 6. Endocrine Testing: End-use Estimates & Trend Analysis

Chapter 7. Endocrine Testing Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

List of Tables

List of Figures